11741 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2009)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3307)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (236)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11741)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)
    Meeting Abstract

    Harrold, E.; Solter, M.; Walch, H. S.; Chatila, W. K.; Keane, F.; Lumish, M. A.; Yaeger, R.; Weiss, J. A.; Palmaira, R. L.; Krishnan, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)
    Meeting Abstract

    Gleeson, J. P.; Harrold, E.; Bromberg, M.; Patel, Z.; Knezevic, A.; Thomas, T.; Ravichandran, V.; Tran, C.; Silber, D.; Carver, B. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy (PFS-2) for metastatic clear cell renal cell carcinoma (ccRCC) in patients treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors
    Meeting Abstract

    Dooley, A.; Han, K.; Zhi, W. I.; Piulson, L.; Seluzicki, C.; Bao, T.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
    Meeting Abstract

    Dinan, M. A.; Stratton, K.; Leisenring, W. M.; Yasui, Y.; Chow, E. J.; Moskowitz, C. S.; Yeh, J. M.; Noyd, D. H.; Armstrong, G. T.; Oeffinger, K. C.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy
    Meeting Abstract

    Daly, R. M.; Nicholas, K.; Flynn, J.; Panageas, K.; Silva, N.; Duck, E.; Zervoudakis, A.; Holland, J. C.; Salvaggio, R.; Begue, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Preliminary analysis of an expanded access study of the fixed-dose combination of pertuzumab (P) and trastuzumab (H) for subcutaneous injection (PH FDC SC) for at-home administration (admin) in patients (pts) with HER2-positive (HER2+) breast cancer (BC) during the COVID-19 pandemic
    Meeting Abstract

    Dang, C. T.; Tolaney, S. M.; Riaz, F.; Tan, A. R.; Tkaczuk, K. H. R.; Yu, A. F.; Liu, J.; Fung, A. M.; Yang, A.; Day, B. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience
    Meeting Abstract

    Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Lu, S. X.; Patel, D.; Maclachlan, K.; Lahoud, O. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Effects of liver metastases on efficacy of immune checkpoint blockade in treatment refractory, metastatic colorectal cancer (CRC): CCTG CO.26
    Meeting Abstract

    Chen, E. X.; Loree, J. M.; Tu, D. S.; O'Callaghan, C. J.; Kennecke, H. F.; Jonker, D. J.; Chaudhary, A.; Colwell, B.; Harb, M.; Aucoin, N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save